InMode Introduces the Morpheus8 Platform and the Morpheus8 Body Fractional Technology
InMode Ltd. (Nasdaq: INMD) has received FDA clearance for its new Morpheus8 Body handpiece and Morpheus8 Platform, making it the first technology to deliver RF energy at a thermal depth of 8mm. This advanced handpiece features 40 gold coated pins, designed for customizable full body fractional treatments. The Morpheus8 Platform includes dual handpieces and fractional tips for various applications. InMode aims to innovate within the RF fractional space, improving treatment options for physicians and patients. The official launch will take place at an event hosted by Dr. Stephen Mulholland from August 14-16, 2020.
- FDA clearance for Morpheus8 Body enhances product portfolio.
- Morpheus8 Body is a breakthrough in RF energy delivery, penetrating deeper than existing technologies.
- The Morpheus8 Platform supports a range of treatments, increasing its market appeal.
- None.
LAKE FOREST, Calif., Aug. 13, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to announce a new FDA clearance to market the Morpheus8 Body handpiece and Morpheus8 Platform.
Morpheus8 Body is the first intelligent, programmable, full body fractional technology to deliver clinically proven RF energy up to a thermal depth of 8mm (7mm pin depth + an additional 1mm thermal profile), with its 40 gold coated pins. As the first and only FDA cleared technology to penetrate subdermal tissue with a thermal profile of 8mm, the new Morpheus8 Body handpiece is designed to provide physicians with a faster, bigger, and better solution to deliver customizable full body fractional treatments. Based on the success of InMode's proprietary technology, the new FDA clearance extends its line of subdermal adipose remodeling devices (SARD).
The new Morpheus8 Body will be launched on a new Morpheus8 Platform, a state-of-the-art workstation complete with dual handpieces and four fractional tips with different microneedle configurations (Prime 12 pin, Resurfacing 24 pin, Morpheus8 24 pin, and Body 40 pin). The Morpheus8 Platform provides physicians with a stand-alone solution for fractional RF, ranging from the Morpheus8 Prime for the treatment of delicate areas with high tissue curvature, to the Morpheus8 Body for large zones. The Morpheus8 Platform will be revealed to the North American market at InMode's 'Main Event' on August 14 – 16, 2020, hosted by internationally renowned plastic surgeon, Dr. Stephen Mulholland.
Shakil Lakhani, InMode President of North America, commented, "With InMode being the leader in the RF fractional space, the addition of these new treatment modalities can provide a customizable, full body solution for each patient. True innovation in the industry has become scarce and this is where InMode will continue to thrive. We are excited about the new treatment capabilities for both our physicians and their patients."
Dr. Stephen Mulholland added, "Morpheus8 has become a standard treatment in my clinic. Whether I use it as a stand-alone treatment for tightening and smoothing of the skin or combined with one of my other treatments, it is my go-to treatment for patients looking for significant, but non-surgical, remodeling improvement."
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.
For more information about InMode, please visit www.inmodemd.com.
Press Contact:
Behrman Communications
Amanda Reinstein
areinstein@behrmanpr.com
Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
917-607-8654
View original content:http://www.prnewswire.com/news-releases/inmode-introduces-the-morpheus8-platform-and-the-morpheus8-body-fractional-technology-301110212.html
SOURCE InMode Ltd.
FAQ
What is the new technology announced by InMode on August 13, 2020?
How deep can the Morpheus8 Body technology penetrate?
What are the features of the Morpheus8 Platform?
When will the Morpheus8 Platform be launched?
Who commented on the innovation of the Morpheus8 Body?
